Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches.

Article Details

Citation
Copy to clipboard

Michael Z, Spyropoulos F, Ghanta S, Christou H

Bronchopulmonary Dysplasia: An Update of Current Pharmacologic Therapies and New Approaches.

Clin Med Insights Pediatr. 2018 Dec 11;12:1179556518817322. doi: 10.1177/1179556518817322. eCollection 2018.

PubMed ID
30574005 [ View in PubMed
]
Abstract

Bronchopulmonary dysplasia (BPD) remains the most prevalent long-term morbidity of surviving extremely preterm infants and is associated with significant health care utilization in infancy and beyond. Recent advances in neonatal care have resulted in improved survival of extremely low birth weight (ELBW) infants; however, the incidence of BPD has not been substantially impacted by novel interventions in this vulnerable population. The multifactorial cause of BPD requires a multi-pronged approach for prevention and treatment. New approaches in assisted ventilation, optimal nutrition, and pharmacologic interventions are currently being evaluated. The focus of this review is the current state of the evidence for pharmacotherapy in BPD. Promising future approaches in need of further study will also be reviewed.

DrugBank Data that Cites this Article

Drugs